Dr. Yoshikazu Inoue is Executive Director at the Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center in Osaka, Japan, and an invited Professor of the Infection, Immunology, and Oncology Cooperating Course, Graduate School, at Osaka University. He studied granulomatous lung diseases during graduate school, and mucin-like glycoproteins when he was an Assistant Professor at Ehime University in Matsuyama, Japan. Previously, he studied granulomatous lung diseases and pulmonary fibrosis at the National Jewish Center for Immunology and Respiratory Medicine in Denver, Colorado. Dr. Inoue’s institute is one of the leading hospitals and research centers for chest diseases, and an important referral center for inflammatory lung diseases in Japan. In addition to their clinical practice, his team is engaged in domestic and international multicenter trials and in basic clinical research. He is a member of the Japan Society of Sarcoidosis and Other Granulomatous Disorders (JSSOG), the Japanese Respiratory Society, the Asian Pacific Society Chapter of the Fleischner Society, Respirology (APSR), American Thoracic Society, European Respiratory Society, World Association of Sarcoidosis and other Granulomatous Disorders (WASOG), and others. Dr. Inoe has served in various capacities in these societies, including Board Member, member of the Executive Committee, Secretary, and Trustee. He has been a WASOG Executive Committee Member since 2011. Dr. Inoue is, and has been, involved in the development of several international guidelines, global clinical trials of pulmonary alveolar proteinosis (PAP), lymphangioleiomyomatosis (LAM), idiopathic interstitial pneumonias (IIPs), idiopathic pulmonary fibrosis (IPF), in addition to acting as an adviser to numerous patient societies and foundations for interstitial lung diseases (ILDs) and PAP.